Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 36, 2022 - Issue 12
204
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Glycosides from Buddleja officinalis with their protective effects on photoreceptor cells in light-damaged mouse retinas

, , , ORCID Icon, , , , , & show all
Pages 3022-3030 | Received 19 Apr 2021, Accepted 08 Jun 2021, Published online: 26 Jun 2021

References

  • American Macular Degeneration Foundation. [date unknown]. Macular degeneration treatments. https://www.macular.org/treatments.
  • Caliş I, Kirmizibekmez H, Tasdemir D, Sticher O, Ireland CM. 2002. Sugar esters from Globularia orientalis. Z Naturforsch C J Biosci. 57(7–8):591–596. c:
  • Chinese Pharmacopoeia Commission. 2020. Pharmacopoeia of the People's Republic of China, vol. 1, Beijing: China Medical Science Press; p. 343.
  • Drexler W, Fujimoto JG. 2008. State-of-the-art retinal optical coherence tomography. Prog Retin Eye Res. 27(1):45–88.
  • Dugel PU, Koh A, Ogura Y, Jaffe GJ, Schmidt-Erfurth U, Brown DM, Gomes AV, Warburton J, Weichselberger A, Holz FG. 2020. HAWK and HARRIER: Phase 3, multicenter, randomized, double-Masked trials of brolucizumab for neovascular age-related macular degeneration. Ophthalmology. 127(1):72–84.
  • Editorial Committee of flora of China. 1992. Chinese Academy of Sciences, Flora of China, vol. 61. Beijing: Science Press; p. 277.
  • Gao YY, Zeng P, Jia CL, Zhang Y, Zhang T, Jia Q, Li YM. 2017. Two new phenols from Lysimachia patungensis. J Asian Nat Prod Res. 19(1):28–34.
  • Guo H, Koike K, Li W, Satou T, Guo D, Nikaido T. 2004. Saponins from the flower buds of Buddleja officinalis. J Nat Prod. 67(1):10–13.
  • Jie CH, Gao JS. 2004. Study of the effect of traditional Chinese herb butterflybush flower on the proliferation of vascular endothelial cells. Yanke. 13(6):348–350.
  • Kim JK, Si CL, Bae YS. 2007. Epimeric phenylpropanoid glycosides from inner bark of Paulownia coreana Uyeki. Holzforschung. 61(2):161–164.
  • Lee C, Lee S, Park SY. 2013. A New Monoterpene from the Flower Buds of Buddleja officinalis. Nat Prod Sci. 19(4):355–359.
  • Li HF, Peng QH, Yao XL, Wang F, Chen JW, Wu QL. 2009. Effects of Buddleja offcinalis flavone on dry eye syndrome and the expression of IL-​1β, TNF-​α in castrated rats. Guoji Yanke Zazhi. 9(7):1248–1251.
  • Li HM, Kim JK, Jang JM, Cui CB, Lim SS. 2013. Analysis of the inhibitory activity of Abeliophyllum distichum leaf constituents against aldose reductase by using high-speed counter current chromatography. Arch Pharm Res. 36(9):1104–1112.
  • Li L, Peng Y, Liu Y, Xu LJ, Guo N, Shi RB, Xiao PG. 2011. Two new phenethanol glycosides from Ligustrum robustum. Chin Chem Lett. 22(3):326–329.
  • Liu X, Li J, Li J, Liu Q, Xun M. 2019. A new flavonoid glycoside from Ligularia fischeri. Chem Nat Compd. 55(4):638–641.
  • Liu YF, Shi GR, Wang X, Zhang CL, Wang Y, Chen RY, Yu DQ. 2016. Chemical constituents from whole plants of Rehmannia chingii. Zhongcaoyao. 47(11):1830–1833.
  • Matsuda H, Cai H, Kubo M, Tosa H, Iinuma M. 1995. Study on anti-cataract drugs from natural sources. II. Effects of buddlejae flos on in vitro aldose reductase activity. Biol Pharm Bull. 18(3):463–466.
  • Ono M, Yoshida A, Ito Y, Nohara T. 1999. Phenethyl alcohol glycosides and isopentenol glycoside from fruit of Bupleurum falcatum. Phytochemistry. 51(6):819–823.
  • Park TW, Lee C, Lee JW, Jang H, Jin Q, Lee MK, Hwang BY. 2016. Chemical constituents from Buddleja officinalis and their inhibitory effects on nitric oxide production. Nat Prod Sci. 22(2):129–133.
  • Porter EA, Kite GC, Veitch NC, Geoghegan IA, Larsson S, Simmonds MSJ. 2015. Phenylethanoid glycosides in tepals of Magnolia salicifolia and their occurrence in flowers of Magnoliaceae. Phytochemistry. 117:185–193.
  • Shen ZH, Zuo ZQ, Liu J. 2016. Effect of Chinese medicine Flos Buddlejae on vascular endothelial growth factor of corneal neovascularization in alkali-burned mice. China J Chin Ophthalmol. 26(3):161–165.
  • Sheng GQ, Zhang JR, Pu XP, Ma J, Li CL. 2002. Protective effect of verbascoside on 1-methyl-4-phenylpyridinium ion-induced neurotoxicity in PC12 cells. Eur J Pharmacol. 451(2):119–124.
  • Tai BH, Jung BY, Cuong NM, Linh PT, Tung NH, Nhiem NX, Huong TT, Anh NT, Kim JA, Kim SK, et al. 2009. Total peroxynitrite scavenging capacity of phenylethanoid and flavonoid glycosides from the flowers of Buddleja officinalis. Biol Pharm Bull. 32(12):1952–1956.
  • Tai BH, Nhiem NX, Quang TH, Ngan NT, Tung NH, Kim Y, Lee JJ, Myung CS, Cuong NM, Kim YH. 2011. A new iridoid and effect on the rat aortic vascular smooth muscle cell proliferation of isolated compounds from Buddleja officinalis. Bioorg Med Chem Lett. 21(11):3462–3466.
  • Taskova RM, Kokubun T, Ryan KG, Garnock-Jones PJ, Jensen SR. 2011. Iridoid and phenylethanoid glucosides from Veronica lavaudiana. J Nat Prod. 74(6):1477–1483.
  • Venditti A, Sanna C, Lorenzetti LM, Ballero M, Bianco A. 2017. New coumarinyl ethers in Daphne oleoides Schreb. collected from Sardinia Island. Chem Biodiversity. 14(6):e1700072.
  • World Health Organization. 2021. Blindness and vision impairment. https://www.who.int/en/news-room/fact-sheets/detail/blindness-and-visual-impairment.
  • Xie G, Xu Q, Li R, Shi L, Han Y, Zhu Y, Wu G, Qin M. 2019. Chemical profiles and quality evaluation of Buddleja officinalis flowers by HPLC-DAD and HPLC-Q-TOF-MS/MS. J Pharm Biomed Anal. 164:283–295.
  • Xu HC, Wang MS, Wu FX, Zhuo LS, Huang W, She NF. 2020. Discovery of N-substituted-3-phenyl-1,6-naphthyridinone derivatives bearing quinoline moiety as selective type II c-Met kinase inhibitors against VEGFR-2. Bioorg Med Chem. 28(12):115555.
  • Yamasaki T, Masuoka C, Nohara T, Ono M. 2007. A new phenylethanoid glycoside from the fruits of Callicarpa japonica Thunb. var. luxurians Rehd. J Nat Med. 61(3):318–322.
  • Yang Y, Yang YB, Lu WQ, Wu ZJ, Chen WS. 2017. A new hydroxyjasmonic acid derivative from Polygonum capitatum. Chem Nat Compd. 53(3):417–421.
  • Zhang HY, Pan JX. 1996. Phenylpropanoid glycosides and flavonoid glycosides isolated from buds of Buddleja officinalis Maxim. J Chin Pharm Sci. 5(2):105–110.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.